Treatment

Showing of 1 - 20 from 138 results
Treatment - Total results - 138
Difficult to stop antidepressant medications, more than half relapse within a year finds study
science

Difficult to stop antidepressant medications, more than half relapse within a year finds study

While 56 percent of the patients who discontinued their medication relapsed during the study, a sizeable portion did not, including most who remained on their antidepressants.

Study finds arthritis-treating drugs tocilizumab, sarilumab help reduce COVID-19 deaths
science

Study finds arthritis-treating drugs tocilizumab, sarilumab help reduce COVID-19 deaths

The analysis included information on 10,930 patients, of whom 6,449 were randomly assigned to receive interleukin-6 inhibitors and 4,481 to receive usual care or placebo.

Explained: What is Peter Pan syndrome and how does one treat it?
India

Explained: What is Peter Pan syndrome and how does one treat it?

"Peter Pan syndrome is not technically a diagnosis, it's a pop psychology term," Ritika Aggarwal, Consultant Psychologist, Jaslok Hospital.

While battling its COVID-19 crisis, India struggles with a ‘Black Fungus’ epidemic
India

While battling its COVID-19 crisis, India struggles with a ‘Black Fungus’ epidemic

PM Modi described the fungal disease as a new “challenge” and said it was “important to create systems to tackle it.”

Too good to be true? Pfizer is working on a pill that could potentially treat COVID-19
science

Too good to be true? Pfizer is working on a pill that could potentially treat COVID-19

Usually, the trials take years, but as the pandemic rages on Pfizer will conduct them in a matter of months.

World Blood Cancer Day: Blood stem cell transplant can give patients a second chance at life
science

World Blood Cancer Day: Blood stem cell transplant can give patients a second chance at life

A blood stem cell transplant can be a potentially life-saving treatment for blood cancer patients.

World TB Day: Shorter treatment plans work when long courses fall through
science

World TB Day: Shorter treatment plans work when long courses fall through

Without treatment, five percent to 10 percent of people with TB infection will develop active TB.

UK study will purposely infect volunteers with COVID-19 to help develop treatment
science

UK study will purposely infect volunteers with COVID-19 to help develop treatment

The study, backed by £33.6 million in government funding, will work with London's Royal Free Hospital to infect around 90 volunteers between 18 and 30 years.

New study finds out how the SARS-CoV-2 virus attaches itself to our cells
science

New study finds out how the SARS-CoV-2 virus attaches itself to our cells

This new study will help scientists in the development of new drugs for treating COVID-19.

Health experts think reinfections could occur with new COVID-19 variants making an appearance
science

Health experts think reinfections could occur with new COVID-19 variants making an appearance

The Brazilian variant caused a spike in hospitalizations in January and revealed a variant that’s more contagious and less vulnerable to some treatments.

New TB treatment will reduce burden of constantly taking pills, cost for infected patients
science

New TB treatment will reduce burden of constantly taking pills, cost for infected patients

Treatment will initially be administered in Ethiopia, Ghana, Kenya, Mozambique and Zimbabwe and seven other nations will follow later.

World AIDS Day 2020: Why it’s important to keep diagnosing, treating AIDS patients during the COVID-19 pandemic
science

World AIDS Day 2020: Why it’s important to keep diagnosing, treating AIDS patients during the COVID-19 pandemic

Lockdowns were essential to slow COVID-19's spread but have had a negative effect on people relying on HIV prevention, care and treatment services.

ICMR gets DCGI nod to conduct clinical trials on humans for new COVID-19 treatment 'Antisera'
India

ICMR gets DCGI nod to conduct clinical trials on humans for new COVID-19 treatment 'Antisera'

Antisera are blood serum high in antibodies against specific antigens and are injected in humans to help kickstart the immune system to fight specific infections.

Russia approves its first Coronavirus vaccine before even completing its clinical trials
science

Russia approves its first Coronavirus vaccine before even completing its clinical trials

The Gamaleya Institute developed the Russian vaccine using a human cell line first cultured in 1973 — the same line used in the Oxford-AstraZeneca vaccine.

Know the enemy: Health experts think understanding the Coronavirus will help us defeat it
World

Know the enemy: Health experts think understanding the Coronavirus will help us defeat it

The coronavirus is invisible, but seemingly everywhere, requires close contact to spread, but reached around the globe faster than any pandemic in history.

CanSino Biologics in talks with Russia, Brazil, Chile, Saudi Arabia to launch Phase III trial of its COVID-19 vaccine
science

CanSino Biologics in talks with Russia, Brazil, Chile, Saudi Arabia to launch Phase III trial of its COVID-19 vaccine

Qiu Dongxu co-founder of CanSino said its new factory under construction in China will allow it to produce 100-200 million vaccine doses per year by early 2021.

Forget antibodies, scientists look towards T-cells in the immune system to fight Coronavirus infection
science

Forget antibodies, scientists look towards T-cells in the immune system to fight Coronavirus infection

There is evidence that T-cells developed after exposure to other coronaviruses that cause the common cold could help fight off SARS-CoV-2.

Neanderthal genes passed down makes some people more prone to COVID-19 infection, a new study proposes
science

Neanderthal genes passed down makes some people more prone to COVID-19 infection, a new study proposes

The Neanderthal gene was found highest in Bangladeshi ancestry, with 63 percent of its population carrying at least one copy of the risk variant.

Researchers debate if infecting people on purpose to test Coronavirus vaccines is ethical
science

Researchers debate if infecting people on purpose to test Coronavirus vaccines is ethical

Human challenge trials have been used to test other vaccines but there were rescue medicines to cure those who got sick. There is no cure for COVID-19.

Oxford's vaccine offers ‘good duration of immunity’ to COVID-19 compared to no vaccine: lead researcher
science

Oxford's vaccine offers ‘good duration of immunity’ to COVID-19 compared to no vaccine: lead researcher

The vaccine has been licensed to AstraZeneca and is in its Phase III of its human trials in the UK.